#SurrogateEndpoints
📣Publicación borradores #IHI @ihieurope.bsky.social

🗓️Apertura ene/27

🔹IHI Call 14 (single)-> 4 topics #NAMs #PersonalisedHealthTech #PatientCare #ATMPs
🔹IHI Call 15 (two-stage)->2 topics #CompassionateUse, #SurrogateEndpoints

🔗 www.horizonteeuropa.es/publicacion-...

@horizonteeuropa.bsky.social
October 16, 2026 at 1:29 PM
📢 JUST PUBLISHED - draft topic texts for calls 14 & 15! There are topics on #NAMs, #ATMPs, #PatientCare, #SurrogateEndpoints, #CompassionateUse, #PersonalisedHealthTech.
👉 www.ihi.europa.eu/news-events/...
❗Be aware: these are drafts. Always consult the final texts!
#HorizonEU #ResearchFunding
October 15, 2026 at 10:24 AM
@EraEdtaRegistry Kitty Jagar outlines some of the problems with running
RCTs in #nephrology #longtime #surrogateendpoints need to predict the clinical endpoint👆🏻 #eraedta19 @ERAEDTA @ynptweets @fjcaskey
November 16, 2024 at 9:06 PM
2024 saw extensions to the SPIRIT and CONSORT reporting guidelines for reporting trials with surrogate endpoints

www.bmj.com/content/386/... (CONSORT-SURROGATE)

www.bmj.com/content/386/... (SPIRIT-SURROGATE)

#statsSky #reporting #clinicaltrials #surrogateendpoints #transparency #
December 29, 2024 at 10:11 AM
Esp. noteworthy - attention drawn to assumptions that #SurrogateEndpoints used for approval are predictive of clinical outcomes.
January 25, 2025 at 4:23 AM
📢New article alert

New Research Article on “Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis”.

🔗 becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #AlzheimersDisease #MetaAnalysis #SurrogateEndpoints
Evaluating amyloid-beta as a surrogate endpoint in trials of anti-amyloid-beta drugs in Alzheimer’s disease: a Bayesian meta-analysis
Aim: The use of amyloid-beta (Aβ) clearance to support regulatory approvals of drugs in Alzheimer’s disease (AD) remains controversial. We evaluate Aβ as a potential trial-level surrogate endpoint for...
becarispublishing.com
December 9, 2025 at 10:34 AM